Enzo Biochem Fiscal Q3 Revenues Decline 22 Percent

Jun 10, 2019

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that total revenues for its fiscal third quarter dropped 22 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent
In Brief This Week: Thermo Fisher Scientific, SpeeDx, Cofactor Genomics, and More
People in the News: Thomas Schinecker, Amelia Warner, Bartu Ahiska, More
Almond Genome Points to Regions Affecting Sweet Taste
New Products Posted to GenomeWeb: BGI Genomics, Oxford Gene Technology, Genestack, More
Bio-Techne Gets New York State Approval for Prostate Cancer Test

The Scan

Collins to Avoid 'Manels'

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Patient Dies Following Fecal Transplant

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

From Pigs to Monkeys

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

This Week in Science

In Science this week: almond reference genome, and more.

Menu